한국   대만   중국   일본 
Broad-spectrum antibiotic - Wikipedia Jump to content

Broad-spectrum antibiotic

From Wikipedia, the free encyclopedia
A colored electron microscopy image of methicillin-resistant staphylococcus aureus ( MRSA ), a bacterium commonly targeted by broad-spectrum antibiotics

A broad- spectrum antibiotic is an antibiotic that acts on the two major bacterial groups, Gram-positive and Gram-negative , [1] or any antibiotic that acts against a wide range of disease-causing bacteria . [2] These medications are used when a bacterial infection is suspected but the group of bacteria is unknown (also called empiric therapy ) or when infection with multiple groups of bacteria is suspected. This is in contrast to a narrow-spectrum antibiotic , which is effective against only a specific group of bacteria . [3] Although powerful, broad-spectrum antibiotics pose specific risks, particularly the disruption of native, normal bacteria and the development of antimicrobial resistance . An example of a commonly used broad-spectrum antibiotic is ampicillin . [3]

Bacterial targets [ edit ]

Antibiotics are often grouped by their ability to act on different bacterial groups. Although bacteria are biologically classified using taxonomy , disease-causing bacteria have historically been classified by their microscopic appearance and chemical function. The morphology of the organism may be classified as cocci , diplococci , bacilli (also known as "rods"), spiral-shaped or pleomorphic. Additional classification occurs through the organism's ability to take up the Gram stain and counter-stain ; bacteria that take up the crystal violet dye stain are referred to as "gram-positive," those that take up the counterstain only are "gram-negative," and those that remain unstained are referred to as "atypical." Further classification includes their requirement for oxygen (i.e., aerobic or anaerobic), patterns of hemolysis , or other chemical properties. The most commonly encountered groupings of bacteria include gram-positive cocci, gram-negative bacilli, atypical bacteria, and anaerobic bacteria. [4] Antibiotics are often grouped by their ability to act on different bacterial groups. For example, 1st-generation cephalosporins are primarily effective against gram-positive bacteria, while 4th-generation cephalosporin s are generally effective against gram-negative bacteria. [ citation needed ]

Empiric antibiotic therapy [ edit ]

Simplified diagram showing common disease-causing bacteria and the antibiotics which act against them.

Empiric antibiotic therapy refers to the use of antibiotics to treat a suspected bacterial infection despite lack of a specific bacterial diagnosis. Definitive diagnosis of the species of bacteria often occurs through culture of blood, sputum, or urine, and can be delayed by 24 to 72 hours. [5] Antibiotics are generally given after the culture specimen has been taken from the patient in order to preserve the bacteria in the specimen and ensure accurate diagnosis. [4] Alternatively, some species may be identified through a urine or stool test. [4]

Risks [ edit ]

Disruption of normal microbiome [ edit ]

There are an estimated 38 trillion microorganisms that colonize the human body. [6] As a side-effect of therapy, antibiotics can change the body's normal microbial content by attacking indiscriminately both the pathological and naturally occurring, beneficial or harmless bacteria found in the intestines, lungs and bladder. [7] The destruction of the body's normal bacterial flora is thought to disrupt immunity, nutrition, and lead to a relative overgrowth in some bacteria or fungi. [8] An overgrowth of drug-resistant microorganisms can lead to a secondary infection such as Clostridioides difficile ("C. diff") or candidiasis ("thrush"). [3] This side-effect is more likely with the use of broad-spectrum antibiotics, given their greater potential to disrupt a larger variety of normal human flora. [7] The use of doxycycline in acne vulgaris has been associated with increased risk of Crohn's disease , [9] although a later study indicated a link between acne vulgaris and IBS irrespective of the use of antibiotics. [10] Likewise, the use of minocycline in acne vulgaris has been associated with skin and gut dysbiosis. [11]

Examples of broad-spectrum antibiotics [ edit ]

In humans : [ citation needed ]

In veterinary medicine , co-amoxiclav , (in small animals); penicillin & streptomycin and oxytetracycline (in farm animals); penicillin and potentiated sulfonamides (in horses).

References [ edit ]

  1. ^ Ory EM, Yow EM (July 1963). "The use and abuse of the broad spectrum antibiotics". JAMA . 185 (4): 273?9. doi : 10.1001/jama.1963.03060040057022 . PMID   13940450 .
  2. ^ Clayton L. Thomas, ed. (1993). Taber's Cyclopedic Medical Dictionary (17th ed.). F. A. Davis Co. ISBN   978-0-8036-8313-6 .
  3. ^ a b c Hopkins SJ (1997). Drugs and Pharmacology for Nurses (12th ed.). Churchill Livingstone. ISBN   978-0-443-05249-1 .
  4. ^ a b c Kasper DL, Larry Jameson J, Hauser SL, Loscalzo J, Fauci AS, Longo DL (2015-04-08). Harrison's principles of internal medicine (19th ed.). New York. ISBN   9780071802154 . OCLC   893557976 . {{ cite book }} : CS1 maint: location missing publisher ( link )
  5. ^ Leekha S, Terrell CL, Edson RS (February 2011). "General principles of antimicrobial therapy" . Mayo Clinic Proceedings . 86 (2): 156?67. doi : 10.4065/mcp.2010.0639 . PMC   3031442 . PMID   21282489 .
  6. ^ Sender R, Fuchs S, Milo R (2016). "Revised Estimates for the Number of Human and Bacteria Cells in the Body" . PLOS Biology . 14 (8): e1002533. doi : 10.1371/journal.pbio.1002533 . PMC   4991899 . PMID   27541692 .
  7. ^ a b Martin EA (2003). Oxford Concise Medical Dictionary (6th ed.). Oxford University Press. ISBN   978-0-19-860753-3 .
  8. ^ Rafii F, Sutherland JB, Cerniglia CE (December 2008). "Effects of treatment with antimicrobial agents on the human colonic microflora" . Therapeutics and Clinical Risk Management . 4 (6): 1343?58. doi : 10.2147/tcrm.s4328 . PMC   2643114 . PMID   19337440 .
  9. ^ Margolis, David J.; Fanelli, Matthew; Hoffstad, Ole; Lewis, James D. (2010). "Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease" . The American Journal of Gastroenterology . 105 (12): 2610?2616. doi : 10.1038/ajg.2010.303 . ISSN   1572-0241 . PMID   20700115 . S2CID   20085592 .
  10. ^ Taylor, Matthew T.; Margolis, David J.; Kwatra, Shawn G.; Barbieri, John S. (April 2023). "A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin use, with risk of incident inflammatory bowel disease" . Journal of the American Academy of Dermatology . 88 (4): 841?847. doi : 10.1016/j.jaad.2023.01.014 . ISSN   1097-6787 . PMC   10033360 . PMID   36682724 .
  11. ^ Thompson, Katherine G.; Rainer, Barbara M.; Antonescu, Corina; Florea, Liliana; Mongodin, Emmanuel F.; Kang, Sewon; Chien, Anna L. (2020-02-01). "Minocycline and Its Impact on Microbial Dysbiosis in the Skin and Gastrointestinal Tract of Acne Patients" . Annals of Dermatology . 32 (1): 21?30. doi : 10.5021/ad.2020.32.1.21 . ISSN   1013-9087 . PMC   7992645 . PMID   33911705 .
  12. ^ Coon ER, Quinonez RA, Morgan DJ, Dhruva SS, Ho T, Money N, Schroeder AR (April 2019). "2018 Update on Pediatric Medical Overuse: A Review". JAMA Pediatrics . 173 (4): 379?384. doi : 10.1001/jamapediatrics.2018.5550 . PMID   30776069 . S2CID   73495617 .
  13. ^ McMullan BJ, Mostaghim M (June 2015). "Prescribing azithromycin" . Australian Prescriber . 38 (3): 87?9. doi : 10.18773/austprescr.2015.030 . PMC   4653965 . PMID   26648627 .